marstacimab-hncq

CHEBI:CHEBI_749777

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
dosage_form
INJECTION, SOLUTION
route
SUBCUTANEOUS
marketing_category
BLA
active_ingredient_strength
150 mg/mL
labeler_name
Pfizer Laboratories Div Pfizer Inc
manufacturer_name
Pfizer Laboratories Div Pfizer Inc
marketing_start_date
20241105
package_marketing_start_date
20241105
generic_name
marstacimab-hncq
brand_name
HYMPAVZI
brand_name_base
HYMPAVZI
product_ndc
0069-2151
application_number
BLA761369
spl_id
a2cc631e-13a6-40c2-acf9-065ccedfb90a
spl_set_id
a2cc631e-13a6-40c2-acf9-065ccedfb90a
active_ingredient_name
MARSTACIMAB
package_ndc
0069-2151-01
package_description
1 SYRINGE in 1 CARTON (0069-2151-01) / 1 mL in 1 SYRINGE
rxcui
2697146
unii
0UB3OA67O7
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class